DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Alten R, Gomez-Reino J, Durez P. , et al.
Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study.
BMC Musculoskelet Disord 2011;
12: 153
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.